中国执业药师
中國執業藥師
중국집업약사
CHINA LICENSED PHARMACIST
2014年
12期
3-5
,共3页
庞载元%敖茂程%吴贤丽%华毅
龐載元%敖茂程%吳賢麗%華毅
방재원%오무정%오현려%화의
鲍曼不动杆菌%临床分布%耐药性
鮑曼不動桿菌%臨床分佈%耐藥性
포만불동간균%림상분포%내약성
Acinetobacter Baumannii%Clinical Distribution%Drug Resistance
目的:了解我院鲍曼不动杆菌的分布和耐药情况,为临床治疗和预防提供依据。方法:采用Whonet 5.6软件对我院2012-2013年临床分离的351株鲍曼不动杆菌的分布及药敏试验结果进行分析。结果:鲍曼不动杆菌主要来源于痰标本(80.06%),主要分布在ICU(49.32%);其耐药率除头孢哌酮-舒巴坦小于40%以外,对氨苄西林-舒巴坦、哌拉西林-他唑巴坦、头孢他啶、头孢吡肟、亚胺培南、环丙沙星等常用抗菌药的耐药率超过了60%。结论:鲍曼不动杆菌耐药性高,临床应根据药敏试验结果合理选择抗菌药物;加强耐药菌监测与控制管理乃当务之急。
目的:瞭解我院鮑曼不動桿菌的分佈和耐藥情況,為臨床治療和預防提供依據。方法:採用Whonet 5.6軟件對我院2012-2013年臨床分離的351株鮑曼不動桿菌的分佈及藥敏試驗結果進行分析。結果:鮑曼不動桿菌主要來源于痰標本(80.06%),主要分佈在ICU(49.32%);其耐藥率除頭孢哌酮-舒巴坦小于40%以外,對氨芐西林-舒巴坦、哌拉西林-他唑巴坦、頭孢他啶、頭孢吡肟、亞胺培南、環丙沙星等常用抗菌藥的耐藥率超過瞭60%。結論:鮑曼不動桿菌耐藥性高,臨床應根據藥敏試驗結果閤理選擇抗菌藥物;加彊耐藥菌鑑測與控製管理迺噹務之急。
목적:료해아원포만불동간균적분포화내약정황,위림상치료화예방제공의거。방법:채용Whonet 5.6연건대아원2012-2013년림상분리적351주포만불동간균적분포급약민시험결과진행분석。결과:포만불동간균주요래원우담표본(80.06%),주요분포재ICU(49.32%);기내약솔제두포고동-서파탄소우40%이외,대안변서림-서파탄、고랍서림-타서파탄、두포타정、두포필우、아알배남、배병사성등상용항균약적내약솔초과료60%。결론:포만불동간균내약성고,림상응근거약민시험결과합리선택항균약물;가강내약균감측여공제관리내당무지급。
Objective:To understand the clinical distribution and drug resistance situation ofAcinetobacterbau-manniiin our hospital so as to provide a basis for clinical treatment and prevention.Methods:Using Whonet 5.6 software the distribution of 351 strains ofAcinetobacterbaumanniiisolated in our hospital from 2012 to 2013 and drug susceptibility results were analyzed.Results:Acinetobacterbaumanniicollected from sputum specimens(80.06%) was mainly distributed in the ICU(49.32%), and its drug resistance rate to ampicillin-sulbactam, piperacillin-tazobac-tam, ceftazidime, cefepime, imipenem, ciprofloxacin and other commonly used antibiotics was all more than 60%, but to cefoperazone-sulbactam sodium was less than 40%.Conclusion:Owing to the high resistance ofAcinetobac-terbaumannii, the antibacterials in clinical use should be selected reasonably according to the results of drug sensi-tivity. To strengthen the monitoring and control of drug resistance bacteria is a pressing matter of the moment.